[go: up one dir, main page]

AU2012904010A0 - Combination therapy to reduce the risk of and to treat cancer - Google Patents

Combination therapy to reduce the risk of and to treat cancer

Info

Publication number
AU2012904010A0
AU2012904010A0 AU2012904010A AU2012904010A AU2012904010A0 AU 2012904010 A0 AU2012904010 A0 AU 2012904010A0 AU 2012904010 A AU2012904010 A AU 2012904010A AU 2012904010 A AU2012904010 A AU 2012904010A AU 2012904010 A0 AU2012904010 A0 AU 2012904010A0
Authority
AU
Australia
Prior art keywords
risk
reduce
combination therapy
treat cancer
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2012904010A
Inventor
Paul Turner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EaglePharma Pty Ltd
Original Assignee
EaglePharma Pty Ltd
Filing date
Publication date
Application filed by EaglePharma Pty Ltd filed Critical EaglePharma Pty Ltd
Publication of AU2012904010A0 publication Critical patent/AU2012904010A0/en
Abandoned legal-status Critical Current

Links

AU2012904010A 2012-09-14 Combination therapy to reduce the risk of and to treat cancer Abandoned AU2012904010A0 (en)

Publications (1)

Publication Number Publication Date
AU2012904010A0 true AU2012904010A0 (en) 2012-09-27

Family

ID=

Similar Documents

Publication Publication Date Title
PT3033086T (en) Combination therapy for the treatment of cancer
SMT201900024T1 (en) Combination therapy for the treatment of cancer
ZA201207574B (en) Phytocannabinoids in the treatment of cancer
IL242386B (en) Use of eribulin and lenvatinib as combination therapy for treatment of cancer
IL238177A0 (en) Methods and compositions for the treatment of cancer
IL263781A (en) Combination therapy for the treatment of ovarian cancer
EP2903644A4 (en) Treatment of cancer
ZA201300762B (en) Novel combination therapy for the treatment of cancer
IL236321A0 (en) Combination therapy for the treatment of cancer and immunosuppression
GB201217892D0 (en) Treatment of cancer
SI2892925T1 (en) Combination treatment of cancer
IL275636A (en) Therapeutic combination for the treatment of cancer
PL2872176T3 (en) Carboranylporphyrins for use in the treatment of cancer
GB201718726D0 (en) Phytocannabinoids in the treatment of cancer
WO2012106461A9 (en) Combination therapy for treatment of cancer
AU2012904010A0 (en) Combination therapy to reduce the risk of and to treat cancer
GB2519004B (en) Quinone compounds and their uses for the treatment of cancer
AU2011903754A0 (en) Combination therapy to reduce the risk of and to treat cancer
GB201217890D0 (en) Treatment of cancer
IL233495A0 (en) Combination therapy for the treatment of cancer
AU2012904722A0 (en) Agents for cancer therapy or prophylaxis and uses therefor
AU2012902296A0 (en) Compositions for Therapy and Methods of Treatment
GB201416605D0 (en) Combination therapy to reduce the risk of and to treat cancer
GB201222950D0 (en) Combination treatment of cancer
GB201222949D0 (en) Combination Treatment of Cancer